Director filed to sell about $2.78M of AMLX stock

A Amylyx Pharmaceuticals director told the SEC about a plan to sell $2.78M of Amylyx Pharmaceuticals shares around Oct 5, 2026. The shares were not acquired as compensation. That is a tiny part of all Amylyx Pharmaceuticals shares.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell